Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Feb 5;16(2):e53605.
doi: 10.7759/cureus.53605. eCollection 2024 Feb.

Iatrogenic Amyloid Polyneuropathy Following Domino Liver Transplantation: A Case Report

Affiliations
Case Reports

Iatrogenic Amyloid Polyneuropathy Following Domino Liver Transplantation: A Case Report

Bárbara Junqueira et al. Cureus. .

Abstract

Familial amyloidotic polyneuropathy (FAP) is an autosomal dominant hereditary disorder. In Portugal, it is mainly linked to transthyretin (TTR) mutation, and patients present with length-dependent sensory-motor polyneuropathy, often accompanied by autonomic dysfunction. Treatment options for FAP include liver transplant, and due to the lack of organs, FAP livers began being implanted in patients with severe liver disease in a process known as domino liver transplantation (DLT). We report a case of a 68-year-old Portuguese man, with post-hepatitis C-related cirrhosis liver transplantation, who presented to his family doctor with decreased sensitivity in both feet and weight loss, which were initially attributed to diabetic neuropathy and an adjustment in diabetic medication, respectively. Symptoms evolved to changes in both feet's thermal and painful sensitivity, reduced sensitivity in both hands, diarrhea, and progressive weight loss. At this time, the patient's disclosure of receiving a DLT prompted the correct diagnosis of iatrogenic amyloid polyneuropathy. This case underscores the challenges in diagnosing and managing iatrogenic amyloid polyneuropathy following DLT, highlighting the importance of prompt identification of DLT recipients, active vigilance of these patients via structured monitoring, and increased healthcare providers' awareness of this practice so that early signs of the disease may be recognized.

Keywords: acquired amyloid neuropathy; domino liver transplantation; familial amyloid neuropathy; iatrogenic polyneuropathy; transthyretin amyloidosis.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments. Sekijima Y. J Neurol Neurosurg Psychiatry. 2015;86:1036–1043. - PubMed
    1. Familial amyloid polyneuropathy. Planté-Bordeneuve V, Said G. Lancet Neurol. 2011;10:1086–1097. - PubMed
    1. The molecular biology and clinical features of amyloid neuropathy. Benson MD, Kincaid JC. Muscle Nerve. 2007;36:411–423. - PubMed
    1. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Holmgren G, Ericzon BG, Groth CG, et al. Lancet. 1993;341:1113–1116. - PubMed
    1. Liver transplantation for hereditary transthyretin amyloidosis. Suhr OB, Herlenius G, Friman S, Ericzon BG. Liver Transpl. 2000;6:263–276. - PubMed

Publication types

LinkOut - more resources